Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds SMBC Nikko Downgrades Jounce Therapeutics to Neutral

SMBC Nikko Downgrades Jounce Therapeutics to Neutral

SMBC Nikko analyst David Dai downgrades Jounce Therapeutics (NASDAQ:JNCE) from Outperform to Neutral.

byBenzinga Newsdesk

February 24, 2023

1 minute read

SMBC Nikko analyst David Dai downgrades Jounce Therapeutics (NASDAQ:JNCE) from Outperform to Neutral.

News

A Look Into Healthcare Sector Value Stocks

By Benzinga Insights

October 2, 10:43 AM

What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices…

ARCT

Analyst Ratings

Analyst Ratings for IQVIA Hldgs

By Benzinga Insights

November 21, 4:00 PM

Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter: Bullish Somewhat Bullish Indifferent…

IQV

Wells Fargo Maintains Equal-Weight on Landstar System, Lowers Price Target to $147

By Benzinga Newsdesk

July 15, 8:06 AM

Wells Fargo analyst Allison Poliniak Cusic maintains Landstar System (NASDAQ:LSTR) with a Equal-Weight and lowers the price target from $165 to $147.

LSTR

Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday

By Avi Kapoor

January 10, 11:27 AM

U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. (NASDAQ: MDRX) shares fell sharply during Wednesday’s session.

AEHR

SMBC Nikko Downgrades Jounce Therapeutics to Neutral

Related Posts

A Look Into Healthcare Sector Value Stocks

Analyst Ratings for IQVIA Hldgs

Wells Fargo Maintains Equal-Weight on Landstar System, Lowers Price Target to $147

Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday